1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Asthma and COPD Therapies Market Forecast 2015-2025: Opportunities for Leading Companies

Asthma and COPD Therapies Market Forecast 2015-2025: Opportunities for Leading Companies

  • October 2015
  • -
  • Visiongain
  • -
  • 309 pages

Summary

Table of Contents

Please note: The license is valid for 12 months from the date the report is sent.


Report Details
Asthma and COPD Therapies Market Forecast 2015-2025: Opportunities for Leading Companies
What can be expected from the Asthma and COPD Therapies market? Which areas are going to grow at the fastest rates? Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.

Our 309-page report provides 260 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. You will see financial results, interviews, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2015-2025 and other analyses show you commercial prospects
Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and Porter’s Five Forces analysis) and commercial developments.

See revenue forecasts for the leading submarkets and therapies
How will submarkets perform to 2025? Our study forecasts revenues in the following asthma and COPD therapies submarkets:
- Combination drugs
- Anti-inflammatory drugs
- Corticosteroids
- Anti-Leukotrienes
- Monoclonal antibodies
- Other anti-inflammatories
- Bronchodilator monotherapy
- Short-acting beta2-agonist (SABAs)
- Long-acting beta2-agonist (LABAs)
- Anticholinergics

How will individual therapies perform to 2025? Our study forecasts revenues for 27 therapies including 5 promising pipeline candidates:
- Ventolin
- ProAir
- Proventil
- Xopenex
- Foradil
- Serevent
- Arcapta/Onbrez
- Brovana
- Spiriva
- Atrovent
- Eklira/Tudorza/Bretaris
- Flixotide/Flovent
- Pulmicort
- QVAR
- Asmanex
- Singulair
- Xolair
- Cinquil
- Mepolizumab
- Benralizumab
- Lebrikizumab
- Dupilumab
- Advair/Seretide
- Symbicort
- Combivent
- Dulera
- Breo/Relvar Ellipta

See revenue forecasts for the leading international markets
How will leading national markets perform to 2025? Our study forecasts revenues in national markets including products, including:
- US
- Japan
- EU5
- BRIC
- Mexico

Leading companies and potential for market growth
Overall revenue for the Asthma and COPD Therapies market will reach $35.87in 2019, our work forecasts. We predict strong revenue growth through to 2025. An ageing population and increasing incidence of respiratory diseases globally will drive sales to 2025.

Our work analyses the key companies in the market. See visiongain’s analysis of 7 leading companies, including these:
- GSK
- Boehringer Ingelheim
- AstraZeneca
- Merck
- Novartis
- Roche
- Teva

A company profile gives you the following information where available:
- 10 year revenue forecast for respiratory products with annual growth rates
- Discussion of a company’s activities and outlook
- Analysis of products currently on the market as well as those in the pipeline

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the Asthma and COPD Therapies industry?
Our new report discusses issues and events affecting the Asthma and COPD Therapies market. You will find discussions, including qualitative analyses:
- Highly diverse market needing strong knowledge of national markets
- Patent expiry challenging major market players
- Emerging areas of therapies with potential to reshape the market

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Asthma and COPD Therapies Market Forecast 2015-2025 report helps you
In summary, our 309-page report gives you the following knowledge:
- Revenue forecasts to 2025 for the asthma and COPD therapies market – discover the industry’s prospects, finding promising places for investments and revenues
- Revenue forecasts to 2025 for submarkets and leading therapies in each – discover prospects for leading drugs in the following asthma and COPD submarkets: bronchodilator monotherapy (including SABAs, LABAs and anticholinergics), anti-inflammatory drugs (including corticosteroids, anti-leukotrienes and monoclonal antibodies) and combination drugs
- Revenue forecasts to 2025 for the leading regional markets – US, Japan, EU5, BRIC and Mexico
- Assessment of 7leading companies – analysis of respiratory revenues, products and pipeline
- Discussion of what stimulates and restrains companies and the market
- Prospects for established firms and those seeking to enter the market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the Asthma and COPD therapies market and leading companies. You find data, trends and predictions. Please order our report now.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Colorectal Cancer (CRC) Market, considering the sales of both branded treatments and generic chemotherapy, is expected ...

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...

Hnscc: Kol Insight - 2017

March 2017 $ 8355

Download Unlimited Documents from Trusted Public Sources

Anti-Infective Market in the Netherlands and Germany

  • April 2017
    10 pages
  • Anti-Infective  

  • Netherlands  

    Germany  

    Europe  

View report >

Cardiovascular Disease Statistics in the US and the UK

  • April 2017
    8 pages
  • Cardiovascular ...  

    Therapy  

  • United States  

View report >

Opioid Market and Digestive System Disorder Statistics in the US

  • April 2017
    20 pages
  • Opioid  

    Digestive Syste...  

  • United States  

View report >

Cranberry Industry

15 days ago

Related Market Segments :

Therapy
Asthma

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.